KD of METTL3 or METTL14 expression reduced mRNA m6A levels, enhanced the growth and self-renewal of GSCs in vitro, and promoted the ability of GSCs to form brain tumors in vivo. The gene discussed is METTL3; the disease is brain neoplasm.